For over 45 years, ABEC has exclusively focused on providing customized process solutions and services for the development and manufacturing of the entire range of biopharmaceutical products, including vaccines, antibodies, recombinant proteins, and gene therapy. Privately held and entrepreneurial since inception, our responsiveness and flexibility are essential to our customers’ success, and therefore inherently built into our DNA. With our complete in-house capabilities and industry-leading capacity, no other provider in the industry can match ABEC’s speed in delivering process solutions for COVID-19 biotherapeutics.
ABEC is supporting multiple industry leaders in their efforts to advance COVID-19 vaccines and therapeutic antibodies. These companies are utilizing ABEC’s full range of customized capabilities, including site services, single-use systems, and stainless-steel equipment. ABEC can:
https://abec.s3.amazonaws.com/ABEC+Corporate+Video+April2021.mp4
The COVID-19 crisis is unique, but ABEC as a company is inherently designed to respond to it. Our long-term commitment to the industry in the form of innovation and investment is well documented. Whether reconfiguring existing capacity for COVID-19 therapeutics or building new, email us at michal.mihalik@cadvision.sk
